Page last updated: 2024-11-09

benzoylacrylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzoylacrylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID676116
CHEMBL ID16365
SCHEMBL ID312429
MeSH IDM0352548

Synonyms (60)

Synonym
HMS1579K08
AC-14424
4-oxo-4-phenylbut-2-enoic acid
BB 0218773
F2103-0016
(e)-4-oxo-4-phenyl-but-2-enoic acid
ai3-26616
4-oxo-4-phenyl-2-butenoic acid
nsc 143
einecs 209-496-5
4-phenyl-4-oxo-2-butenoic acid
(2e)-4-oxo-4-phenylbut-2-enoic acid
STK358786
583-06-2
acrylic acid, 3-benzoyl-
.beta.-benzoylacrylic acid
3-benzoylacrylic acid
benzoylacrylic acid
crotonic acid, 4-oxo-4-phenyl-
2-butenoic acid, 4-oxo-4-phenyl-
nsc-143
nsc143
inchi=1/c10h8o3/c11-9(6-7-10(12)13)8-4-2-1-3-5-8/h1-7h,(h,12,13)/b7-6
AKOS000267606
4-oxo-4-phenyl-but-2-enoic acid
bdbm50125821
CHEMBL16365 ,
A831824
(e)-4-oxo-4-phenylbut-2-enoic acid
BBL007891
AE-641/02009001
17812-07-6
trans-3-benzoylacrylic acid
AB01332184-02
SCHEMBL312429
7N-710
ss-benzoylacrylic acid
4-oxo-4-phenylcrotonic acid
DTXSID1060392
ss-benzoyl-acrylsaure
trans-beta-benzoylacrylic acid
(e)-4-oxo-4-phenyl-2-butenoic acid
W-111702
A1-01400
trans-3-benzoylacrylicacid
2-butenoic acid, 4-oxo-4-phenyl-, (2e)-
3-benzoylacrylic acid, predominantly trans
mfcd00014015
(2e)-4-oxo-4-phenyl-2-butenoic acid
CS-0040775
3-benzoyl acrylic acid
NCGC00341436-01
noname_745
DTXSID30901612
AS-57498
CS-0368601
EN300-18942
4-oxo-4-phenylbut-2-enoicacid
EN300-1588441
Z2895088074

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
" These mt-QSARs offer also a good opportunity to construct drug-drug Complex Networks (CNs) that can be used to explore large and complex drug-viral species databases."( Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E, 2009
)
0.35
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))IC50 (µMol)500.00001.88004.68805.8600AID160322; AID666158
ALK tyrosine kinase receptorHomo sapiens (human)IC50 (µMol)500.00000.00010.310710.0000AID666158
Cysteine protease ATG4BHomo sapiens (human)IC50 (µMol)580.00000.63003.06558.9000AID1904111
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))EC50 (µMol)250.00003.22003.22003.2200AID666145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (34)

Processvia Protein(s)Taxonomy
protein autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
signal transductionALK tyrosine kinase receptorHomo sapiens (human)
cell surface receptor protein tyrosine kinase signaling pathwayALK tyrosine kinase receptorHomo sapiens (human)
phosphorylationALK tyrosine kinase receptorHomo sapiens (human)
hippocampus developmentALK tyrosine kinase receptorHomo sapiens (human)
adult behaviorALK tyrosine kinase receptorHomo sapiens (human)
swimming behaviorALK tyrosine kinase receptorHomo sapiens (human)
peptidyl-tyrosine autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
regulation of apoptotic processALK tyrosine kinase receptorHomo sapiens (human)
protein autophosphorylationALK tyrosine kinase receptorHomo sapiens (human)
neuron developmentALK tyrosine kinase receptorHomo sapiens (human)
negative regulation of lipid catabolic processALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of NF-kappaB transcription factor activityALK tyrosine kinase receptorHomo sapiens (human)
regulation of dopamine receptor signaling pathwayALK tyrosine kinase receptorHomo sapiens (human)
response to environmental enrichmentALK tyrosine kinase receptorHomo sapiens (human)
energy homeostasisALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of dendrite developmentALK tyrosine kinase receptorHomo sapiens (human)
regulation of neuron differentiationALK tyrosine kinase receptorHomo sapiens (human)
regulation of cell population proliferationALK tyrosine kinase receptorHomo sapiens (human)
multicellular organism developmentALK tyrosine kinase receptorHomo sapiens (human)
positive regulation of kinase activityALK tyrosine kinase receptorHomo sapiens (human)
protein delipidationCysteine protease ATG4BHomo sapiens (human)
autophagosome assemblyCysteine protease ATG4BHomo sapiens (human)
mitophagyCysteine protease ATG4BHomo sapiens (human)
proteolysisCysteine protease ATG4BHomo sapiens (human)
autophagyCysteine protease ATG4BHomo sapiens (human)
protein transportCysteine protease ATG4BHomo sapiens (human)
macroautophagyCysteine protease ATG4BHomo sapiens (human)
microautophagyCysteine protease ATG4BHomo sapiens (human)
otolith mineralization completed early in developmentCysteine protease ATG4BHomo sapiens (human)
protein localization to phagophore assembly siteCysteine protease ATG4BHomo sapiens (human)
protein delipidationCysteine protease ATG4BHomo sapiens (human)
protein processingCysteine protease ATG4BHomo sapiens (human)
piecemeal microautophagy of the nucleusCysteine protease ATG4BHomo sapiens (human)
aggrephagyCysteine protease ATG4BHomo sapiens (human)
C-terminal protein lipidationCysteine protease ATG4BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (12)

Processvia Protein(s)Taxonomy
protein tyrosine kinase activityALK tyrosine kinase receptorHomo sapiens (human)
transmembrane receptor protein tyrosine kinase activityALK tyrosine kinase receptorHomo sapiens (human)
protein bindingALK tyrosine kinase receptorHomo sapiens (human)
ATP bindingALK tyrosine kinase receptorHomo sapiens (human)
heparin bindingALK tyrosine kinase receptorHomo sapiens (human)
receptor signaling protein tyrosine kinase activator activityALK tyrosine kinase receptorHomo sapiens (human)
identical protein bindingALK tyrosine kinase receptorHomo sapiens (human)
endopeptidase activityCysteine protease ATG4BHomo sapiens (human)
cysteine-type endopeptidase activityCysteine protease ATG4BHomo sapiens (human)
protein bindingCysteine protease ATG4BHomo sapiens (human)
cysteine-type peptidase activityCysteine protease ATG4BHomo sapiens (human)
protein-phosphatidylethanolamide deconjugating activityCysteine protease ATG4BHomo sapiens (human)
scaffold protein bindingCysteine protease ATG4BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (11)

Processvia Protein(s)Taxonomy
extracellular regionPolymerase acidic proteinInfluenza A virus (A/Puerto Rico/8/1934(H1N1))
plasma membraneALK tyrosine kinase receptorHomo sapiens (human)
plasma membraneALK tyrosine kinase receptorHomo sapiens (human)
extracellular exosomeALK tyrosine kinase receptorHomo sapiens (human)
protein-containing complexALK tyrosine kinase receptorHomo sapiens (human)
receptor complexALK tyrosine kinase receptorHomo sapiens (human)
autophagosome membraneCysteine protease ATG4BHomo sapiens (human)
mitochondrionCysteine protease ATG4BHomo sapiens (human)
endoplasmic reticulumCysteine protease ATG4BHomo sapiens (human)
cytosolCysteine protease ATG4BHomo sapiens (human)
cytoplasmic vesicleCysteine protease ATG4BHomo sapiens (human)
cytoplasmCysteine protease ATG4BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID160322Inhibitory concentration against cap-dependent endonuclease activity of influenza virus RNP2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
Use of a pharmacophore model to discover a new class of influenza endonuclease inhibitors.
AID666145Plaque growth inhibition2012ACS chemical biology, Mar-16, Volume: 7, Issue:3
Identification of influenza endonuclease inhibitors using a novel fluorescence polarization assay.
AID125801Antimicrobial activity against Microsporum canis(ATCC 11621) was determined1987Journal of medicinal chemistry, Sep, Volume: 30, Issue:9
3-Carbonylacrylic derivatives as potential antimicrobial agents. Correlations between activity and reactivity toward cysteine.
AID23452Partition coefficient (logP)1987Journal of medicinal chemistry, Sep, Volume: 30, Issue:9
3-Carbonylacrylic derivatives as potential antimicrobial agents. Correlations between activity and reactivity toward cysteine.
AID1904111Inhibition of recombinant ATG4B (unknown origin) expressed in Escherichia coli BL21(DE3) pLysS cells using LC3-GST as substrate incubated for 3 hrs by coomassie brilliant blue staining based assay2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
AID666158Inhibition of cap 1 ALMV primed Influenza transcriptase1994Antimicrobial agents and chemotherapy, Dec, Volume: 38, Issue:12
Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.
AID210257Antimicrobial activity against Streptococcus pyogenes A(IVM P 134) was determined1987Journal of medicinal chemistry, Sep, Volume: 30, Issue:9
3-Carbonylacrylic derivatives as potential antimicrobial agents. Correlations between activity and reactivity toward cysteine.
AID608240Antiproliferative activity against human K562 cells assessed as inhibition of cell survival after 72 hrs by MTT method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Antiproliferative activity of aroylacrylic acids. Structure-activity study based on molecular interaction fields.
AID1904112Inhibition of PLA2 (unknown origin)2022Journal of medicinal chemistry, 03-24, Volume: 65, Issue:6
Discovery and Structure-Based Optimization of Novel Atg4B Inhibitors for the Treatment of Castration-Resistant Prostate Cancer.
AID608239Antiproliferative activity against human LS 174T cells assessed as inhibition of cell survival after 72 hrs by MTT method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Antiproliferative activity of aroylacrylic acids. Structure-activity study based on molecular interaction fields.
AID608238Antiproliferative activity against human HeLa cells assessed as inhibition of cell survival after 72 hrs by MTT method2011European journal of medicinal chemistry, Aug, Volume: 46, Issue:8
Antiproliferative activity of aroylacrylic acids. Structure-activity study based on molecular interaction fields.
AID207499Antimicrobial activity against Staphylococcus aureus(ATCC 6538) was determined1987Journal of medicinal chemistry, Sep, Volume: 30, Issue:9
3-Carbonylacrylic derivatives as potential antimicrobial agents. Correlations between activity and reactivity toward cysteine.
AID1536845Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 4 days by microplate Alamar blue assay2019Bioorganic & medicinal chemistry letters, 02-15, Volume: 29, Issue:4
Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
AID392531Antiviral activity against influenza virus2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (16.67)18.7374
1990's2 (11.11)18.2507
2000's3 (16.67)29.6817
2010's8 (44.44)24.3611
2020's2 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.90

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.90 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.90)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]